These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8380944

  • 1. [Cytomegalovirus and blood transfusion].
    Eggen BM.
    Tidsskr Nor Laegeforen; 1993 Jan 10; 113(1):22-4. PubMed ID: 8380944
    [Abstract] [Full Text] [Related]

  • 2. Risk of cytomegalovirus transmission by blood products to immunocompromised patients and means for reduction.
    Ljungman P.
    Br J Haematol; 2004 Apr 10; 125(2):107-16. PubMed ID: 15059132
    [No Abstract] [Full Text] [Related]

  • 3. Transfusion-transmitted cytomegalovirus infection.
    Bowden RA.
    Hematol Oncol Clin North Am; 1995 Feb 10; 9(1):155-66. PubMed ID: 7737939
    [Abstract] [Full Text] [Related]

  • 4. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB, Przepiorka D, Tarrand J, Chan KW, Champlin R, Lichtiger B.
    Bone Marrow Transplant; 1998 Sep 10; 22(6):575-7. PubMed ID: 9758346
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Posttransfusion cytomegalovirus infections.
    Tegtmeier GE.
    Arch Pathol Lab Med; 1989 Mar 10; 113(3):236-45. PubMed ID: 2537614
    [Abstract] [Full Text] [Related]

  • 8. Transfusion-transmitted cytomegalovirus: lessons from a murine model.
    Roback JD, Su L, Zimring JC, Hillyer CD.
    Transfus Med Rev; 2007 Jan 10; 21(1):26-36. PubMed ID: 17174218
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative.
    Smith D, Lu Q, Yuan S, Goldfinger D, Fernando LP, Ziman A.
    Vox Sang; 2010 Jan 10; 98(1):29-36. PubMed ID: 19695013
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. High prevalence of cytomegalovirus DNA in plasma samples of blood donors in connection with seroconversion.
    Ziemann M, Krueger S, Maier AB, Unmack A, Goerg S, Hennig H.
    Transfusion; 2007 Nov 10; 47(11):1972-83. PubMed ID: 17958525
    [Abstract] [Full Text] [Related]

  • 13. Reducing the risk for transfusion-transmitted cytomegalovirus infection.
    Sayers MH, Anderson KC, Goodnough LT, Kurtz SR, Lane TA, Pisciotto P, Silberstein LE.
    Ann Intern Med; 1992 Jan 01; 116(1):55-62. PubMed ID: 1309201
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recognition of cytomegalovirus clinical isolate antigens by sera from cytomegalovirus-negative blood donors.
    Rahbar AR, Sundqvist VA, Wirgart BZ, Grillner L, Söderberg-Naucler C.
    Transfusion; 2004 Jul 01; 44(7):1059-66. PubMed ID: 15225248
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cytomegalovirus infectivity in whole blood following leukocyte reduction by filtration.
    Lipson SM, Shepp DH, Match ME, Axelrod FB, Whitbread JA.
    Am J Clin Pathol; 2001 Jul 01; 116(1):52-5. PubMed ID: 11447751
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Leukocyte depletion of blood products. Indications and technical implementation].
    Böck M, Heim MU.
    Fortschr Med; 1995 Mar 20; 113(8):102-4. PubMed ID: 7759031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.